Company intelligence
Lung Cancer Research Foundation
Our vision is a world free of lung cancer.
About Lung Cancer Research Foundation
The Lung Cancer Research Foundation (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF’s mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer. To date, LCRF has awarded 429 research grants, totaling $48 million to investigators around the world. In addition to funding lung cancer research, the organization focuses on lung cancer awareness and educational programs, like its monthly #TogetherSeparately webinar series. Its Free to Breathe fundraising events bring the lung cancer community together in support of lung cancer research.
Verified activity
Signals from Lung Cancer Research Foundation
7 published signals
Research & Knowledge
Lung Cancer Research Foundation announced results from the Phase III DeLLphi-305 trial for people with ES-SCLC.
Reported by Lung Cancer Research Foundation
Presence & Recognition
Lung Cancer Research Foundation announced that AbbVie is presenting as a National Presenting Sponsor for the Free to Breathe events program.
Reported by Lung Cancer Research Foundation
Presence & Recognition
Lung Cancer Research Foundation sponsored the Free to Breathe Chicago Walk as a sponsor.
Reported by Lung Cancer Research Foundation
Presence & Recognition
Lung Cancer Research Foundation is hosting the Free to Breathe Kansas City Walk on Saturday, September 26 at Longview Lake Shelter 13
Reported by Lung Cancer Research Foundation
Presence & Recognition
Lung Cancer Research Foundation sponsors the National Free to Breathe Walk with Pfizer, AbbVie, Bayer, Boehringer Ingelheim, Johnson & Johnson, Merck, and Summit Therapeutics, Inc.
Reported by Lung Cancer Research Foundation
Research & Knowledge
Lung Cancer Research Foundation funded Dr. John Brognard's lab investigation of the protein TNIK as a potential drug target in squamous cell lung cancer.
Reported by Lung Cancer Research Foundation
Presence & Recognition
Lung Cancer Research Foundation spotlighted Maiyan Chau, PhD, Medical Strategy Lead, Lung Cancer for AstraZeneca on Women Wednesday
Reported by Lung Cancer Research Foundation